Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influen
According to a new, phase 2 clinical trial led by Dana-Farber Cancer Institute doctors, a three-medicine combination that drove chronic lymphocytic leukaemia (CLL) patients into profound remissions in a clinical study is very beneficial in patients with high-risk variants of the disease.
The treatment, which is referred to as a "bispecific antibody," binds to both T cells and multiple myeloma cells and instructs the T cells, which are white blood cells that can be used to fight off diseases
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report
According to a recent study published in the scientific journal Annals of Allergy, Asthma and Immunology of the American College of Allergy, Asthma and Immunology (ACAAI), targeted cognitive behavioural therapy (CBT) can significantly reduce anxiety related to food allergies (FAA) in both ch
Mumbai (Maharashtra) [India], December 7 (ANI/BusinessWire India): Male and female pattern hair loss, also known as androgenic alopecia, continues to remain a prominent area of concern, especially in the age groups of 25 and onwards.
Testosterone therapy can have numerous risks which patients need to have information of before undertaking it. And according to a new study published in the journal named "JAMA Internal Medicine", not many of these platforms are providing the appropriate guidelines for its safe and effective
According to study, obesity is a serious illness that can result in cardiovascular diseases, diabetes, hypertension, and chronic inflammation. For this reason, researchers have long been attempting to find effective treatments.
Scientists at the University of Birmingham in the UK and Beijing Normal University in China, demonstrated that the therapy, which is non-invasive, could improve short-term, or working memory in people by up to 25 per cent.
In September 2021, Pele received a bowel cancer diagnosis. He had a respiratory infection, which led to his hospitalization on Tuesday where his cancer therapy was reviewed.
In September 2021, Pele received a bowel cancer diagnosis. He had a respiratory infection, which led to his hospitalization on Tuesday where his cancer therapy was reviewed.